Trials / Unknown
UnknownNCT05850780
Clinical and Radiographic Evaluation of Laser Photobiomodulation Pulpotomy of Primary Molars in Children
Clinical and Radiographic Evaluation of Laser Photobiomodulation Pulpotomy of Primary Molars in Children (A Randomized Controlled Clinical Trial)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (estimated)
- Sponsor
- Aliaa Hamouda · Academic / Other
- Sex
- All
- Age
- 5 Years – 7 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to evaluate the clinical and radiographic outcomes of photobiomodulation pulpotomy compared to MTA pulpotomy in primary molars in children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Photobiomodulation | A diode laser (Sirolaser blue laser system, Sirona Dental Systems GmbH, Fabrikstraße 31, 64625 Bensheim, Germany) Wavelength 660 nm will be used, and the laser parameters will be set as follows: Power 0.1 W, energy 6 J, Continuous wave; energy Tip area 0.5 cm2, fluence 12 J/cm2 will be applied to the surface of the pulp stumps for 60 seconds. The pulp chamber will then be filled with reinforced zinc oxide-eugenol (IRM, Dentsply, Mount Waverley, Australia) to ensure proper sealing. Then, each tooth in both groups will finally be restored with a stainless-steel crown (SSC)40 (3M/ESPE, St. Paul, Minn., USA) in the same visit, which will be cemented onto the tooth using glass ionomer cement. Finally, reapplication of laser with the same parameters will be done around inserted crowns to promote tissue healing and decrease post operative pain. |
| DRUG | MTA | Three parts of MTA powder will be mixed with one part of distilled water to obtain paste. This mixture will then be placed on the radicular pulp stumps and condensed lightly with a moistened cotton pellet. then the access cavities will be sealed with glass ionomer cement |
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2024-06-01
- Completion
- 2024-06-01
- First posted
- 2023-05-09
- Last updated
- 2023-05-09
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05850780. Inclusion in this directory is not an endorsement.